DVAX
Dynavax Technologies Corp
Price:  
10.30 
USD
Volume:  
3,059,180.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Intrinsic Value

-89.70 %
Upside

What is the intrinsic value of DVAX?

As of 2025-06-20, the Intrinsic Value of Dynavax Technologies Corp (DVAX) is 1.06 USD. This DVAX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 10.30 USD, the upside of Dynavax Technologies Corp is -89.70%.

The range of the Intrinsic Value is 0.72 - 1.43 USD

Is DVAX undervalued or overvalued?

Based on its market price of 10.30 USD and our intrinsic valuation, Dynavax Technologies Corp (DVAX) is overvalued by 89.70%.

10.30 USD
Stock Price
1.06 USD
Intrinsic Value
Intrinsic Value Details

DVAX Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (10.05) - (3.51) (4.53) -144.0%
DCF (Growth 10y) (1.44) - 2.83 (0.79) -107.7%
DCF (EBITDA 5y) 0.72 - 1.43 1.06 -89.7%
DCF (EBITDA 10y) 2.28 - 4.08 3.11 -69.8%
Fair Value -12.51 - -12.51 -12.51 -221.42%
P/E (7.54) - 10.70 0.46 -95.5%
EV/EBITDA (1.01) - 3.81 0.62 -94.0%
EPV 7.66 - 11.61 9.63 -6.5%
DDM - Stable (5.94) - (32.26) (19.10) -285.4%
DDM - Multi 7.64 - 32.80 12.46 20.9%

DVAX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 1,236.82
Beta 0.45
Outstanding shares (mil) 120.08
Enterprise Value (mil) 1,445.61
Market risk premium 4.60%
Cost of Equity 7.65%
Cost of Debt 5.50%
WACC 7.29%